However, insulin injections, as well as stimulating insulin release or reducing circulatory glucose and lipid levels with hypoglycemic and hypolipidemic agents, have been shown to protect against DCM in diabetic subjects and animal models with T1DM and T2DM [3,10,56,59]. The gene discussed is INS; the disease is type 1 diabetes mellitus.